Albany Molecular Research, Inc. Announces Third Quarter Results; Continues Double-Digit Growth in Contract Revenue and EPS

ALBANY, N.Y.--(BUSINESS WIRE)--AMRI (NASDAQ: AMRI) today announced results for the third quarter ended September 30, 2007. For the quarter, the company reported growth in total contract revenue and net income. Growth was driven by continued strong performance in the company’s Development/Small Scale business component. Highlights for the quarter include:

MORE ON THIS TOPIC